dr tyna moore glp 1 EP. 172: GLP-1 Agonists and the Gut Microbiome: Unveiling Their Role in Metabolic Health 2360: What You Need to
Description
Bridging the gap between clinical potential and real-world impact enables stakeholders to decode the complex interplay of these forces and rethink what it truly takes to keep patients on the path to sustained outcomes
Buy now.
Join Omada as we review the good, the bad, and the necessary when it comes to compounded GLP-1s and the role of virtual care in supporting GLP-1 programs.
This overlooked research reveals a fix thats simple, cheap, and almost entirely ignored.
